Jeremy Springall is currently the Director of Biochemical and Biophysical Methods at AstraZeneca, leading a team of nine scientists in advancing quality control methodologies and laboratory automation technologies. Previously, Jeremy held various roles at GlaxoSmithKline and AstraZeneca, focusing on analytical development for biopharmaceuticals and participating in numerous external committees and workshops. Jeremy earned a PhD in Medicinal Chemistry and Biochemistry, as well as a Bachelor's degree in Chemistry from the University of Bath.
This person is not in any teams
This person is not in any offices